PE Firm Platinum Offers $2.1B For J&J Glucose Testing Unit
Johnson & Johnson said Friday that private equity firm Platinum Equity LLC had offered to acquire its glucose monitoring unit LifeScan Inc. for around $2.1 billion in a deal that would...To view the full article, register now.
Already a subscriber? Click here to view full article